ALZN logo

Alzamend Neuro (ALZN) Free Cash Flow

ALZN Annual FCF

-$8.42 M
+$506.00 K+5.67%

30 April 2024

ALZN Free Cash Flow Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ALZN Quarterly FCF

-$3.40 M
-$2.25 M-196.77%

31 October 2024

ALZN Quarterly FCF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ALZN TTM FCF

-$8.00 M
-$1.89 M-30.84%

31 October 2024

ALZN TTM FCF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ALZN Free Cash Flow Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+5.7%-196.8%-30.8%
3 y3 years-210.4%-196.8%-30.8%
5 y5 years-705.3%-196.8%-30.8%

ALZN Free Cash Flow High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-210.4%+5.7%-196.8%+1.3%-50.1%+18.6%
5 y5-year-705.3%+5.7%-1557.8%+1.3%-3802.6%+18.6%
alltimeall time-705.3%+5.7%-1557.8%+1.3%-3802.6%+18.6%

Alzamend Neuro Free Cash Flow History

DateAnnualQuarterlyTTM
Oct 2024
-
-$3.40 M(+196.8%)
-$8.00 M(+30.8%)
July 2024
-
-$1.15 M(-19.7%)
-$6.12 M(-27.3%)
Apr 2024
-$8.42 M(-5.7%)
-$1.43 M(-29.8%)
-$8.42 M(-8.8%)
Jan 2024
-
-$2.03 M(+34.2%)
-$9.23 M(+2.5%)
Oct 2023
-
-$1.51 M(-56.1%)
-$9.00 M(-8.5%)
July 2023
-
-$3.45 M(+54.1%)
-$9.83 M(+10.2%)
Apr 2023
-$8.92 M(+32.8%)
-$2.24 M(+23.7%)
-$8.92 M(+8.2%)
Jan 2023
-
-$1.81 M(-22.9%)
-$8.25 M(+0.3%)
Oct 2022
-
-$2.34 M(-7.6%)
-$8.23 M(+3.8%)
July 2022
-
-$2.54 M(+62.4%)
-$7.93 M(+19.9%)
DateAnnualQuarterlyTTM
Apr 2022
-$6.72 M(+147.8%)
-$1.56 M(-12.4%)
-$6.61 M(+4.8%)
Jan 2022
-
-$1.78 M(-12.9%)
-$6.31 M(+18.3%)
Oct 2021
-
-$2.05 M(+67.4%)
-$5.33 M(+43.0%)
July 2021
-
-$1.22 M(-2.8%)
-$3.73 M(+37.5%)
Apr 2021
-$2.71 M(+15.6%)
-$1.26 M(+56.0%)
-$2.71 M(+86.5%)
Jan 2021
-
-$806.10 K(+82.0%)
-$1.45 M(+124.4%)
Oct 2020
-
-$442.90 K(+115.9%)
-$648.00 K(+215.9%)
July 2020
-
-$205.10 K
-$205.10 K
Apr 2020
-$2.35 M(+124.4%)
-
-
Apr 2019
-$1.05 M
-
-

FAQ

  • What is Alzamend Neuro annual free cash flow?
  • What is the all time high annual FCF for Alzamend Neuro?
  • What is Alzamend Neuro annual FCF year-on-year change?
  • What is Alzamend Neuro quarterly free cash flow?
  • What is the all time high quarterly FCF for Alzamend Neuro?
  • What is Alzamend Neuro quarterly FCF year-on-year change?
  • What is Alzamend Neuro TTM free cash flow?
  • What is the all time high TTM FCF for Alzamend Neuro?
  • What is Alzamend Neuro TTM FCF year-on-year change?

What is Alzamend Neuro annual free cash flow?

The current annual FCF of ALZN is -$8.42 M

What is the all time high annual FCF for Alzamend Neuro?

Alzamend Neuro all-time high annual free cash flow is -$1.05 M

What is Alzamend Neuro annual FCF year-on-year change?

Over the past year, ALZN annual free cash flow has changed by +$506.00 K (+5.67%)

What is Alzamend Neuro quarterly free cash flow?

The current quarterly FCF of ALZN is -$3.40 M

What is the all time high quarterly FCF for Alzamend Neuro?

Alzamend Neuro all-time high quarterly free cash flow is -$205.10 K

What is Alzamend Neuro quarterly FCF year-on-year change?

Over the past year, ALZN quarterly free cash flow has changed by -$2.25 M (-196.77%)

What is Alzamend Neuro TTM free cash flow?

The current TTM FCF of ALZN is -$8.00 M

What is the all time high TTM FCF for Alzamend Neuro?

Alzamend Neuro all-time high TTM free cash flow is -$205.10 K

What is Alzamend Neuro TTM FCF year-on-year change?

Over the past year, ALZN TTM free cash flow has changed by -$1.89 M (-30.84%)